Pharma Sector Overview
| Dr. Reddy's Laboratories Ltd. | 19.89% | 16.54% | 14.86% | 29.61% | 29.61% | 27.09% | 21.55% | 1.27% | 18.60% | 17.54% | 1,04,932.72 Cr |
| Cipla Ltd. | 9.19% | 6.88% | 133.05% | 26.99% | 28.92% | 17.97% | 30.09% | 27.89% | 18.04% | 19.13% | 1,19,713.07 Cr |
| Lupin Ltd. | 14.24% | 13.48% | 11.45% | 24.32% | 24.13% | 6.80% | 114.58% | 71.11% | 13.81% | 14.56% | 88,217.49 Cr |
| Biocon Ltd. | 12.76% | 3.43% | 23.09% | 26.17% | 29.93% | 27.34% | 154.87% | -1.05% | 10.40% | 9.37% | 47,873.93 Cr |
| Divi's Laboratories Ltd. | 12.24% | 19.31% | -52.90% | 37.60% | 35.47% | 34.09% | 23.11% | 36.93% | 25.61% | 23.41% | 1,78,700.46 Cr |
| Piramal Pharma Ltd. | 7.90% | 11.99% | 140.74% | 22.48% | 18.06% | 13.95% | 50.65% | 392.86% | 5.57% | 1.00% | 27,997.19 Cr |
| Jubilant Pharmova Ltd. | 9.68% | 7.93% | 5.68% | 18.18% | 26.94% | 15.49% | 363.14% | 988.09% | 7.84% | 11.56% | 19,623.42 Cr |
| Alembic Pharmaceuticals Ltd. | 16.66% | 7.12% | 132.54% | 16.13% | 16.15% | 15.15% | -12.02% | -5.27% | 8.85% | 8.72% | 20,273.51 Cr |
| Laurus Labs Ltd. | 19.49% | 10.18% | 124.09% | 27.79% | 20.42% | 23.84% | 210.00% | 123.15% | 13.53% | 6.45% | 44,596.14 Cr |
| Ajanta Pharma Ltd. | 11.04% | 10.44% | 140.51% | 26.94% | 29.13% | 19.61% | 11.80% | 13.48% | 19.25% | 19.80% | 34,635.6 Cr |
| JB Chemicals & Pharmaceuticals Ltd. | 10.18% | 12.45% | -45.53% | 25.37% | 27.31% | 24.62% | 13.87% | 19.04% | 15.34% | 16.83% | 25,750.53 Cr |
| Glaxosmithkline Pharmaceuticals Ltd. | 4.79% | 8.56% | -51.46% | 38.37% | 35.55% | 27.00% | 35.19% | 57.22% | 26.98% | 24.74% | 53,166.38 Cr |
| Eris Lifesciences Ltd. | 28.02% | 44.02% | 29.03% | 36.92% | 35.79% | 33.57% | 32.18% | -10.31% | 14.51% | 12.95% | 24,002.81 Cr |
| Marksans Pharma Ltd. | 26.51% | 20.46% | 20.72% | 20.08% | 22.84% | 21.20% | 15.61% | 21.39% | 12.81% | 14.59% | 11,589.67 Cr |
| Aarti Drugs Ltd. | 9.16% | -5.60% | -54.22% | 14.07% | 12.71% | 12.71% | 33.59% | -1.13% | 9.28% | 7.04% | 4,775.25 Cr |
| Aarti Pharmalabs Ltd. | 11.47% | 14.17% | -43.93% | 25.55% | 22.43% | 18.75% | 35.42% | 25.62% | 15.67% | 12.88% | 8,622.07 Cr |
| IOL Chemicals And Pharmaceuticals Ltd. | 4.73% | -2.51% | 111.94% | 12.75% | 10.81% | 12.28% | 13.83% | -24.89% | 5.95% | 4.86% | 2,694.59 Cr |
| Caplin Point Laboratories Ltd. | 10.86% | 14.37% | 148.05% | 38.59% | 38.37% | 34.84% | 17.11% | 17.25% | 28.91% | 27.93% | 15,987.54 Cr |
| Hikal Ltd. | 7.45% | 4.21% | -1.44% | 22.43% | 17.93% | 15.29% | 47.46% | 30.50% | 9.09% | 4.88% | 4,232.31 Cr |
| Morepen Laboratories Ltd. | 10.11% | 7.17% | -51.07% | 10.06% | 10.62% | 8.80% | -35.19% | 17.02% | 4.36% | 6.51% | 3,426.36 Cr |
| Sai Life Sciences Ltd. | 31.94% | 15.66% | 24.91% | 28.85% | 26.11% | 18.44% | 36.77% | 93.22% | 15.23% | 10.04% | 16,989.91 Cr |
| Nectar Lifesciences Ltd. | -2.42% | -0.74% | 0.08% | -31.40% | -1.29% | 8.01% | -19433.33% | -2404.55% | -26.49% | -5.95% | 400.08 Cr |
| Neuland Laboratories Ltd. | -14.71% | -5.24% | -46.25% | 17.83% | 33.62% | 25.80% | -58.85% | -13.32% | 8.47% | 17.61% | 18,299.29 Cr |
| Onesource Specialty Pharma Ltd. | 482.36% | 740.42% | 124.22% | 43.53% | 18.15% | -152.41% | 189.04% | 98.27% | 23.29% | -1.20% | 22,834.56 Cr |
| Solara Active Pharma Sciences Ltd. | -8.82% | -0.40% | 116.31% | 18.80% | 16.72% | 3.92% | 98.61% | 100.09% | -0.77% | 0.04% | 3,261.36 Cr |
| Innova Captab Ltd. | 19.84% | 15.02% | 15.82% | 16.22% | 15.94% | 13.57% | 2.99% | 20.10% | 9.40% | 10.31% | 5,157.68 Cr |
| Acutaas Chemicals Ltd. | 37.13% | 40.34% | -42.15% | 29.41% | 24.73% | 20.10% | 127.41% | 239.79% | 20.33% | 15.93% | N/A |
| Bliss GVS Pharma Ltd. | -0.07% | 5.13% | -52.33% | 16.75% | 20.15% | 20.47% | 267.05% | 10.93% | 8.41% | 11.15% | 1,693.72 Cr |
| Advanced Enzyme Technologies Ltd. | 5.93% | 2.09% | 6.36% | 32.51% | 35.72% | 36.16% | -6.32% | -1.68% | 15.99% | 21.04% | 3,629.98 Cr |
| Kopran Ltd. | -7.37% | 2.44% | -49.10% | 11.81% | 12.21% | 14.85% | -47.93% | -24.41% | 5.61% | 6.12% | 859.58 Cr |
| Wanbury Ltd. | 23.38% | 4.15% | -51.05% | 18.30% | 13.31% | 8.15% | -39.88% | -45.50% | 11.78% | 5.09% | 898.4 Cr |
| Sudarshan Pharma Industries Ltd. | N/A | 8.95% | -47.90% | N/A | 7.29% | 4.03% | N/A | 37.50% | N/A | 3.16% | N/A |
| Syncom Formulations (India) Ltd. | 99.64% | 76.55% | -40.40% | 16.60% | 15.39% | 15.48% | 60.00% | 67.65% | 11.89% | 10.63% | 1,765.32 Cr |
| Fredun Pharmaceuticals Ltd. | N/A | N/A | N/A | 10.30% | 12.03% | N/A | N/A | N/A | 3.59% | 4.33% | N/A |
| Senores Pharmaceuticals Ltd. | 11.49% | 85.65% | 204.04% | 27.33% | 27.36% | 28.00% | -52.55% | 17.92% | 15.73% | 14.65% | 2,875.36 Cr |
| Kwality Pharmaceuticals Ltd. | 25.77% | 20.52% | -56.71% | 23.04% | 22.23% | 28.65% | 241.91% | 68.54% | 12.52% | 10.75% | N/A |
| Beta Drugs Ltd. | N/A | 22.54% | -41.80% | N/A | 19.84% | 22.70% | N/A | 10.87% | N/A | 11.71% | N/A |
| Bharat Parenterals Ltd. | 53.32% | 32.26% | -45.65% | 4.00% | 4.21% | 13.98% | -2222.58% | -367.20% | -9.08% | -12.83% | N/A |
| Mangalam Drugs And Organics Ltd. | -28.56% | -13.66% | N/A | 14.20% | 11.41% | N/A | -98.21% | 174.17% | 0.08% | 2.11% | 136.82 Cr |
| Hester Biosciences Ltd. | 3.37% | 2.15% | 9.80% | 16.53% | 22.20% | 22.17% | -75.80% | 36.21% | 1.88% | 9.27% | 1,640.04 Cr |
| Alembic Ltd. | 22.90% | 40.89% | -34.29% | 124.41% | 150.84% | 76.36% | -4.98% | 15.68% | 113.57% | 140.01% | 3,042.61 Cr |
| Kilitch Drugs (India) Ltd. | 36.61% | 28.47% | -44.21% | 26.61% | 21.49% | 15.05% | 188.84% | 81.03% | 16.69% | 12.58% | 738.66 Cr |
| Sakar Healthcare Ltd. | 16.68% | 15.80% | -48.26% | 31.66% | 28.66% | 26.71% | 82.19% | 41.31% | 11.47% | 9.86% | 775.71 Cr |
| Natural Capsules Ltd. | 11.81% | 8.87% | -49.96% | 10.42% | 10.77% | 15.30% | -90.08% | -96.47% | 1.16% | 0.36% | N/A |
| Gennex Laboratories Ltd. | 20.36% | 59.03% | -98.69% | 13.76% | 19.47% | 14.90% | -12.50% | 19.40% | 7.61% | 13.14% | N/A |
| Valiant Laboratories Ltd. | 88.92% | -26.74% | N/A | 2.62% | 0.57% | N/A | 148.48% | -492.31% | 1.22% | -1.65% | 446.62 Cr |
| Alpa Laboratories Ltd. | 69.10% | 3.41% | -53.56% | 6.70% | 24.99% | 19.67% | -155.56% | 16.60% | -5.32% | 17.34% | 218.15 Cr |
| Shree Ganesh Remedies Ltd. | -34.55% | -13.74% | N/A | 49.78% | 39.54% | 29.47% | -48.75% | -19.61% | 26.97% | 21.24% | N/A |
| Trident Lifeline Ltd. | N/A | 94.86% | -26.35% | N/A | 26.55% | 20.59% | N/A | 85.14% | N/A | 12.07% | N/A |
| Brooks Laboratories Ltd. | 31.57% | 3.86% | -55.10% | -2.72% | -8.68% | -16.99% | 85.68% | 51.50% | -6.25% | -12.07% | N/A |
| Walpar Nutritions Ltd. | N/A | 14.78% | -35.51% | N/A | 8.34% | 7.56% | N/A | 47.62% | N/A | 3.90% | N/A |
| Sanjivani Paranteral Ltd. | N/A | N/A | N/A | 16.72% | 16.50% | N/A | N/A | N/A | 12.02% | 11.55% | N/A |
| Vivo Bio Tech Ltd. | 4.53% | 2.69% | -55.05% | 42.06% | 54.24% | 40.08% | 38.00% | 180.00% | 8.65% | 15.60% | N/A |
| Suven Life Sciences Ltd. | -38.49% | -43.08% | -61.70% | -2903.68% | -2326.86% | -932.63% | -65.57% | -52.90% | -2995.57% | -2415.04% | 6,346.39 Cr |
Pharma Sector Summary
Revenue Growth (YoY)
13.84%
Average ROE
N/A
Average ROCE
N/A
EBITDA Margin
26.55%
PAT Margin
15.25%
EBITDA Margin (3Y)
N/A
PAT Margin (3Y)
N/A
Total Companies
54
* Q3 represents quarterly (latest quarter) data comparison
* 1 Y represents yearly comparison
* 3 Y represents 3-year rolling average
* TTM represents Trailing Twelve Months
* CAGR represents Compound Annual Growth Rate over 3 years
* M.Cap represents Market Capitalization
* P/E represents Price to Earnings ratio
* P/S represents Price to Sales ratio
* P/BV represents Price to Book Value ratio
* EV/EBITDA represents Enterprise Value to EBITDA ratio
* ROE represents Return on Equity
* ROCE represents Return on Capital Employed
* ROA represents Return on Assets
* All financial figures are in INR
* N/A indicates data not available or not applicable